Table 3.
Characteristics of the studies included in the review.
| Experimental Group | Control Group | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Characteristics | Experimental Intervention Characteristics | Sample Characteristics | Type Control Intervention |
||||||||||||||
| Author and Year | Country | Design | K | N | Ne | Age (Range or Mean ± SD) |
% Fem |
Type of CP |
GMFCS Level | Type | Dura- tion (weeks) |
Session/Week | Minutes/Session | Nc | Age (Range or Mean ± SD) |
% Fem | |
| Acar, G et al. 2016 [57] | Turkey | RCT | 1 | 30 | 15 | 9.53 ± 3.04 | 46% | Spastic hemiparesis | I/II | NWT + CT | 6 | 2 | 15 | 15 | 9.73 ± 2.86 | 60 | CT |
| Alsaif, A et al. 2015 [58] | Saudi Arabia | RCT | 4 | 40 | 20 | 6–10 y | NR | Spastic bilateral hemiparesis | III | NWT | 12 | 7 | 20 | 20 | 6–10 y | NR | NI |
| Atasavun-Uysal, SA et al. 2016 [59] | Turkey | RCT | 1 | 24 | 12 | 9.13 ± 2.57 | 33% | Spastic unilateral | I/II | NWT + CT | 12 | 2 | 30 | 12 | NR | 83% | CT |
| Avcil, E et al. 2020 [60] | Turkey | RCT | 4 | 30 | 15 | 10.93 ± 4.09 | 46% | NR | I/II/III/IV | NWT + LMC | 8 | 3 | 60 | 15 | 11.07 ± 3.24 | 40 | CT |
| Chiu, HC et al. 2014 [61] | Australia | RCT | 3 | 57 | 30 | 9.4 ± 1.9 | 50% | Spastic hemiplejic | I/II/III/IV/IV | NWT + CT | 12 | 3 | 40 | 27 | 9.5 ± 1.9 | 59% | CT |
| El-Shamy, SM et al. 2018 [62] | Saudi Arabia | RCT | 2 | 40 | 20 | 9.5 ± 1.2 | 40% | Spastic hemiplejic | NR | NWT + CT | 12 | 3 | 40 | 20 | 9.8 ± 1.2 | 30% | CT |
| Sajan, JE et al. 2017 [63] | India | RCT | 3 | 18 | 9 | 10.6 ± 3.78 | 40% | Spastic bilateral | I/II/III/IV | NWT + CT | 3 | 6 | 45 | 9 | 12.4 ± 4.93 | 50% | CT |
| Shin, JW et al. 2015 [64] | South Korea | RCT | 1 | 17 | 8 | 106.8 ± 2.5 months | 63% | Spastic bilateral | NR | NWT | 8 | 2 | 45 | 9 | 110.8 ± 16.1 months | 33% | CT |
| Wang, TN et al. 2021 [65] | China | RCT | 1 | 18 | 9 | 102.67 ± 25.05 months | 66% | Spastic hemiplejic | NR | NWT + CT | 8 | 2 | 145 | 9 | 102.78 ± 25.84 months | 44% | CT |
Abbreviations: K, Number of comparisons; N, Number of participants in study; Ne, Number of participants in experimental group; Nc, Number of participants in control group; SD, Standard Deviation; Fem, Female; CP, Cerebral Palsy; GMFCS, Gross Motor Function Classification System; RCT, Randomized Controlled Trial; NR, Not reported; NWT, Nintendo® Wii Therapy; LMC, Leap Motion Controller; NI, No intervention; CT, Conventional Therapy.